YOLFTbeta
P&K Skin Research Center Co. Ltd

P&K Skin Research Center Co. Ltd

347740 · KQ · Healthcare / Diagnostics & Research

1,802.00KRW-8.00 (-0.44%)

Price History

Full chart

Market Stats

Previous Close1,810.00
Open1,801.00
Day Range1,797.00 – 1,816.00
52-Week Range1,292.00 – 2,757.67
Volume3.80K
Market Cap47.65B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield3.03%
Beta0.83
50-Day Avg1,796.02
200-Day Avg2,096.13

About

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded in 2010 and is headquartered in Seoul, South Korea. P&K Skin Research Center Co., Ltd. is a subsidiary of Daebongls.Co.,Ltd.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOHae-gwang Lee
  • Employees98
  • HeadquartersKorea Educational Facility Safety Institute, Seoul, South Korea, 07236, Korea
  • Websitehttps://www.pnkskin.com

Leadership

  • Hae-gwang LeeChief Executive Officer

Financials

Income Statement

Currency: KRW2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue10.02B12.50B14.68B17.49B17.96B14.84B17.85B22.78B
Growth (%)-+24.77%+17.43%+19.15%+2.69%-17.34%+20.24%+27.66%
Cost of Revenue2.62B3.35B4.35B6.19B6.84B7.64B9.37B12.07B
Gross Profit7.40B9.15B10.33B11.30B11.11B7.20B8.48B10.71B
Gross Margin73.88%73.21%70.39%64.61%61.89%48.50%47.49%47.02%
Operating Expense2.83B3.47B3.11B4.84B5.47B5.82B5.89B6.77B
Operating Income4.57B5.68B7.22B6.46B5.64B1.38B2.58B3.94B
Operating Margin45.61%45.41%49.17%36.95%31.41%9.29%14.47%17.29%
EBITDA----9.68B7.12B8.67B7.86B
EBITDA Margin----53.93%48.00%48.59%34.48%
Net Income3.88B5.38B6.72B7.29B7.13B4.81B5.82B4.69B
Net Income Margin38.75%43.01%45.78%41.71%39.71%32.43%32.59%20.56%
R&D--852.73M1.26B1.67B1.36B1.52B1.62B
R&D as % of Total Revenue--5.81%7.22%9.30%9.14%8.51%7.13%
Interest Expense0022.22M29.86M25.77M32.77M26.49M52.29M
Interest Expense % of Total Revenue0.00%0.00%0.15%0.17%0.14%0.22%0.15%0.23%

Balance Sheet

Currency: KRW2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets17.64B27.97B59.89B67.09B74.54B77.41B82.04B86.52B
Total Liabilities1.68B3.47B4.27B4.03B3.73B3.17B5.10B6.04B
Total Equity15.96B24.50B55.63B63.07B70.81B74.20B76.94B80.64B
Cash374.86K1.11M3.89B194.09K838.79K9.80B6.46B3.97B
Total Debt-749.51M621.88M-----

Cash Flow

Currency: KRW2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow4.26B6.49B8.67B7.70B7.51B5.55B9.03B6.68B
Investing Cash Flow-6.15B-3.33B-37.41B-9.81B-4.32B972.22M-8.87B-
Financing Cash Flow-2.99B24.20B-263.72M283.73M-1.71B-3.49B-
Capital Expenditure655.80M541.19M1.05B2.81B1.36B1.56B622.12M1.50B
Free Cash Flow-6.38B7.61B4.89B6.15B3.99B8.41B5.18B
Dividends Paid----892.93M872.08M714.68M976.98M
FCF to OCF-98.18%87.83%63.49%81.93%71.89%93.11%77.49%
Dividend Paid to FCF----14.52%21.86%8.50%18.87%

Earnings

Report DateSep 30, 2020Mar 19, 2021May 16, 2021Aug 16, 2021Nov 15, 2021Mar 17, 2022Mar 31, 2022Jun 30, 2022Sep 30, 2022Mar 20, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 28, 2024Mar 31, 2024Jun 30, 2024Sep 30, 2024Mar 28, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------
EPS Actual56.12139.7167.2573.0044.5061.7146.8851.0156.2984.6747.6414.0730.9867.7944.5537.4180.9237.5581.5655.8455.20-30.3651.4752.92
Surprise------------------------
Timing--After-hoursAfter-hoursPre-marketPre-market---Pre-market---Pre-market---Pre-market------

Key Statistics & Ratios

Market Cap47.65B
Enterprise Value17.48B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.01
Price / Book0.60
Revenue (TTM)23.67B
Gross Profit (TTM)11.13B
EBITDA5.69B
Profit Margin15.77%
Operating Margin22.89%
Return on Equity4.49%
Return on Assets2.65%
Shares Outstanding28.88M
Shares Float11.05M
Beta0.83
Dividend Yield3.03%
Dividend Rate50.00
Payout Ratio38.69%

Dividends

20251×
50.00Dec 29, 2025
20241×
40.00Dec 27, 2024
20231×
30.00Dec 27, 2023
20221×
35.00Dec 28, 2022
20211×
37.50Dec 29, 2021

Stock Splits

  • Jul 26, 20224:1